BANK VONTOBEL/PUT/ABBOTT LABORATORIES/86/0.1/20.09.24 Stock

Warrant

DE000VM3MCY3

Market Closed - Deutsche Boerse AG 01:53:25 2024-07-16 pm EDT
0.017 EUR -15.00% Intraday chart for BANK VONTOBEL/PUT/ABBOTT LABORATORIES/86/0.1/20.09.24
Current month-10.53%
1 month-41.38%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.017 -15.00%
24-07-15 0.02 +5.26%
24-07-12 0.019 -26.92%
24-07-11 0.026 -23.53%
24-07-10 0.034 -20.93%

Delayed Quote Deutsche Boerse AG

Last update July 16, 2024 at 01:53 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VM3MCY
ISINDE000VM3MCY3
Date issued 2023-10-06
Strike 86 $
Maturity 2024-09-20 (66 Days)
Parity 10 : 1
Emission price 0.45
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.63
Lowest since issue 0.013
Spread 0.01
Spread %35.71%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
102.7 USD
Average target price
124.8 USD
Spread / Average Target
+21.48%
Consensus